Navigation Links
US Patient Implanted With HeartMate II, Leaves ICU

HearMate II is yet to gain approval from the Food and Drug Administration (FDA), but the Barnes-Jewish Hospital in Missouri has implanted it in Wilson Guthrie, a 61-year-old man from Kansas, suffering from end-stage heart failure.

He has since left for home, with that experimental heart-assist device that keeps his heart pumping.

Hospital officials said it's the longest stay the cardiothoracic ICU has had, and that a lot of technology was used to keep Wilson Guthrie alive.

"We're very excited to see him go home," Guthrie's sister, Teresa Rico, a family practitioner, said. "He's a lot better."

Guthrie was waiting at home for a heart transplant. But when his condition "profoundly deteriorated" last fall, he was airlifted to Barnes-Jewish for a temporary mechanical heart pump, "to see if he would turn around," his physician, Nader Moazami, said.

"I told the family he has a 90 percent chance of dying," said Moazami, surgical director of the hospital's and Washington University School of Medicine's heart transplant and artificial heart programs.

First the regular mechanical pump was tried out. It is an external device that can only be used in an ICU and is intended to support a patient for a month or two. Over the next few months, his liver function and breathing recovered enough that Guthrie was ready for the next step. But what?

He was reconsidered for a transplant, but with his kidneys still in failure and with intermittent internal bleeding, he was disqualified. The temporary pump kept him captive to the ICU.

Guthrie's small stature made him unsuitable for larger heart pumps, which would not have fit into his body.

The only option was the smaller HeartMate II pump, which wasn't approved by the FDA, and Guthrie's insurance company wouldn't pay for it initially.

Through a series of letters and phone calls to the FDA and Humana Health Car e, Moazami was able to persuade them to allow the compassionate use of the experimental device for Guthrie.

"We had no choice with this gentleman," he said. "He was too healthy not to do anything, but he was stuck in the ICU."

Once the new device was implanted, Guthrie recovered remarkably. His kidney function and physical strength returned, and he got out of the ICU. He has not yet regained his appetite, but "given what he's been through, this is minor," Moazami said.

"He's got nine lives. I think we've used eight of them."

Barnes-Jewish doctors are familiar with HeartMate II because the hospital is one of the institutions participating in the clinical trial.

A small pump implanted in the body, it is attached to a half-inch cable connected to a battery pack that recharges it. It's mobile. Moazami said one of his patients in the clinical trial delivers pizzas.

The device will stay inside Guthrie, and he should do well, as long as it's durable perhaps as long as five years. When it fails, he'll either get a replacement or be considered for a heart transplant.

Guthrie should be hoping to pull through, along with the physicians,not to speak of the HeartMate II manufacturers.


Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patient’s perception of health status helps in better recover
7. Patients often assume wrongly that they are allergic to penicillin
8. New FDA Approved Drug NATRECOR For Heart Failure Patients
9. Hemochromatosis Patients Blood is Safe
10. Fifth US Patient Receives Artificial Heart
11. Patients Pressure Would Result In Overprescription
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation claim ... of hospital and nonhospital care, according to a recent study by the Workers Compensation ... Edition , found medical payments per claim with more than seven days of lost ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... to continue the expansion of the company’s growing product line of food safety ... (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since ... improvements in scientific research and discoveries, leading us to better understand the disease’s ... to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... the 7th Annual 2015 Golden Bridge Business Awards under the New Products and ... zero capex web based sample management software that helps labs organize ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... It’s ... has a tattoo — a number even greater among Millennials (a whopping one in ... are more and more people who are dissatisfied with their ink. In fact, ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , Dec. 1, 2015  The ... (HCOs) to develop shared care plans that help ... These care plans will be digitally enabled, incorporate ... unique needs and desires. They will also allow ... a patient,s health journey is optimal. That is ...
(Date:12/1/2015)... Germany , December 1, 2015 /PRNewswire/ ... leading global manufacturer of eye and gaze tracking solutions, ... SMI remote eye trackers as a component of its ... concussions, eye sight, and medical and performance issues in ... part of SMI,s mass-market-ready eye tracking platform, which is ...
(Date:12/1/2015)... THE WOODLANDS, Texas , Dec. 1, ... LXRX )  announced today that top-line data ... results of telotristat etiprate in treating carcinoid ... tumors consistent with the clinical benefit observed ... study was designed as a companion to ...
Breaking Medicine Technology: